Nordic Society for Precision Medicine
Mission and Background
The Nordic Society for Precision Medicine (NSPM) was created in order to:
- establish a Nordic framework for research into the genetics of human diseases, as well as into human evolution and population history;
- accelerate discovery of disease susceptibility genes and genes protecting from disease through integrated analyses using multiple large-scale datasets and a range of experimental designs;
- translate these findings so that they can be used for precision medicine to improve public health;
- and uphold and promote the highest legal, regulatory, social, and ethical standards.
We will do this by working with pertinent experts and other stakeholders at local, national and regional levels.
The idea for Nordic collaboration was broached at a meeting in Reykjavik, Iceland, in 2014, and set in motion in a series of four meetings--Cold Spring Harbor Laboratory, USA, May 2015; Oslo, Norway, Sept 2016; Copenhagen, Denmark, May, 2017; Malmö, Sweden, December, 2017. In June 2018, we announced the formation of the Nordic Society for Precision Medicine at a meeting in Reykjavik.
Through those meetings and many other interactions, we have formalized the Nordic Precision Medicine Initiative (NPMI). The NPMI has since developed a road map, that will help the Nordic countries achieve their extraordinary potential to become world leaders in precision medicine research.
NPMI Steering Committee
Ole Andreassen, University of Oslo, Norway
Søren Brunak, University of Copenhagen, Denmark
Anders Børglum, Århus University, Denmark
Mark Daly, Institute for Molecular Medicine Finland
Paul Franks, Lund University, Sweden
Leif Groop, Lund University, Sweden
Hakon Heimer, Cold Spring Harbor Laboratory, USA
Eivind Hovig, Oslo University, Norway
Kristian Hveem, Norwegian University of Science and Technology, Norway
Andres Metspalu, University of Tartu, Estonia
Lili Milani, University of Tartu, Estonia
Preben Bo Mortensen, Denmark
Pål Njølstad, University of Bergen, Norway
Juni Palmgren, Karolinska Institute, Sweden
Aarno Palotie, Institute for Molecular Medicine Finland
Samuli Ripatti, Institute for Molecular Medicine Finland
Hreinn Stefánsson, deCODE genetics, Iceland
Kári Stefánsson, deCODE genetics, Iceland
Camilla Stoltenberg, Norwegian Institute of Public Health, Norway
Patrick Sullivan, Karolinska Institute, Sweden
Thomas Werge, Mental Health Centre Sct. Hans, Denmark
Hakon Heimer, NordicPrecisionMedicine@gmail.com